Edinburgh Cancer Informatics's Avatar

Edinburgh Cancer Informatics

@cancerdataedin.bsky.social

The Edinburgh Cancer Informatics Research Group. Using data to improve the care of cancer patients across South East Scotland. https://cancer-data.ecrc.ed.ac.uk/

271 Followers  |  369 Following  |  8 Posts  |  Joined: 18.11.2024  |  1.3101

Latest posts by cancerdataedin.bsky.social on Bluesky

Movember Prostate Cancer Equity Metric Project โ€“ Edinburgh Cancer Informatics

A new collaboration with Movember is underway within the team, with Kevin Gallagher leading a project centred around prostate cancer equity. ๐Ÿฅธ

04.06.2025 14:28 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

ECi were recently invited to showcase our projects at the 2025 CRUK Parliament Reception. Read more about it on our website ๐Ÿ‘‡

cancer-data.ecrc.ed.ac.uk/2025/04/29/e...

29.04.2025 09:02 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

We're hiring!
A vacancy has opened up in the team for the position of Post-Doctoral Research Fellow. ๐Ÿ”ฌ ๐Ÿง‘๐Ÿผโ€๐Ÿ’ป

If this sounds like something you'd be interested in, details can be found on our website below. ๐Ÿ‘‡

cancer-data.ecrc.ed.ac.uk/2025/03/07/r...

07.03.2025 12:23 โ€” ๐Ÿ‘ 0    ๐Ÿ” 1    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

The Sudlow Review on the challenges and opportunities for using UK linked healthcare data for research www.hdruk.ac.uk/helping-with...

02.12.2024 10:34 โ€” ๐Ÿ‘ 1    ๐Ÿ” 1    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

Looking for collaborators to work on federated Real World Evidence studies related to cancer. We are building our infrastructure and need high value demonstaror projects. #OHDSI #EHDEN #OMOP #RWE please get in touch

18.11.2024 12:05 โ€” ๐Ÿ‘ 5    ๐Ÿ” 2    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0

DataLoch, in collaboration with ECi are proud to announce our membership of the UK RWE Network. Operated by HDR UK, we aim to prove the potential of Observational Medical Outcomes Partnership (OMOP) and the Common Data Model (CDM).

Find out more below๐Ÿ‘‡๐Ÿผ
t.co/rj89DIgT4b

18.11.2024 11:56 โ€” ๐Ÿ‘ 3    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 1

Read more about the OMOP Common Data Model used in our studies. ๐Ÿ’ป

t.co/ukStMLuvgc

18.11.2024 11:55 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

Your coffee break reading, sorted. โ˜•๏ธ

Read below to discover the impact of SABR on Stage 1 Non-Small-Cell Cancer Outcomes. ๐Ÿ‘‡

t.co/seMWlyos26

18.11.2024 11:55 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

๐˜“๐˜ถ๐˜ฏ๐˜จ ๐˜ค๐˜ข๐˜ฏ๐˜ค๐˜ฆ๐˜ณ ๐˜ช๐˜ด ๐˜ต๐˜ฉ๐˜ฆ ๐˜ฎ๐˜ฐ๐˜ด๐˜ต ๐˜ค๐˜ฐ๐˜ฎ๐˜ฎ๐˜ฐ๐˜ฏ ๐˜ค๐˜ข๐˜ถ๐˜ด๐˜ฆ ๐˜ฐ๐˜ง ๐˜ค๐˜ข๐˜ฏ๐˜ค๐˜ฆ๐˜ณ ๐˜ฅ๐˜ฆ๐˜ข๐˜ต๐˜ฉ ๐˜ช๐˜ฏ ๐˜ต๐˜ฉ๐˜ฆ ๐˜œ๐˜’.

We teamed up with @cruk-si.bsky.social and NHS Lothian to assess whether early prehabilitation could be feasible in these patients. ๐Ÿ‘‡

t.co/hgeiPjw7bZ

18.11.2024 11:54 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

Take a deep dive into Piyumanga's incredible research project, where she explores the topic of polypharmacy-survival in poor prognosis cancer patients. ๐Ÿคฟ ๐Ÿ‘‡

t.co/Azd0gPf885

18.11.2024 11:52 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

@cancerdataedin is following 20 prominent accounts